Supplementary Figure 3.
The enhancement of PDZ2 interaction with PIP 2 embedded in liposomes in the presence of Frizzled 7 peptide is lost when the PDZ2 carries K214A, K250A or N215D mutations. PDZ1 in isolation strongly interacts with liposomes but shows poor if any interaction with PIP 2 embedded in liposomes. SPR sensorgrams illustrating the binding of PDZ2 K214A (a), PDZ2 K250A (b) and PDZ2 N215D (c) to liposomes containing 30% PC/ 40% PE/ 20% PS / 5% PI and 5% PIP 2 in the absence (black continuous line) or in the presence of 2 mM KGETAV Frizzled 7 peptide (grey continuous line) after substraction of the binding to control liposomes (30% PC/ 40% PE/ 20% PS / 10% PI). d and e. Sensorgrams illustrating the binding of increasing concentrations of PDZ1 wild-type to liposomes containing 30% PC/ 40% PE/ 20% PS and either 10% PI (black line) or 5% PI and 5% PIP 2 (grey line) in the absence (d) 
Supplementary Figure 5.
Representative micrographs used for the quantification of the plasma membrane enrichment of Frizzled 7. MCF-7 cells were transiently transfected with expression vectors for Frizzled 7 wild-type, Frizzled 7 K-5A, Frizzled 7 K-5E, eYFP-PDZ1-PDZ2 tandem wild-type, eYFP-PDZ1-PDZ2 tandem K214A, eYFP-PDZ1-PDZ2 tandem K250A, eYFP-PDZ1-PDZ2 tandem N215D, eYFP-PDZ1-PDZ2 tandem K214A/K250A, phosphatidylinositol 4-phosphate 5-kinase (PIP5K) and/or mCherry-ARF6T27N as indicated. Frizzled 7 (wild-type or mutants) and PIP5K were detected by immunocytochemistry using labeled secondary antibodies and eYFP-PDZ1-PDZ2 tandem (wild-type or mutants) and mCherry-ARF6T27N were detected by direct fluorescence using confocal microscopy. Scale bar, 10 µm. 
